News|Articles|October 31, 2024
Robust Oligonucleotide Molecular Weight Confirmation via LC/MS
Author(s)Agilent Technologies, Inc.
Oligonucleotides—therapeutic agents for difficult-to-treat diseases—rely on precise molecular weight confirmation to ensure quality during development. Experts from Agilent Technologies explore the challenges of liquid chromatography-mass spectrometry (LC/MS) analysis in oligonucleotide synthesis, as well as strategies for accurate deconvolution, method development, and optimal equipment selection.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Trending on LCGC International
1
Green Stabilizers in Nitrocellulose Propellants: VOC Fingerprinting of Accelerated Aging by HS-SPME–GC×GC–TOF-MS
2
Translating Scientific Skills Into Impact: Careers Beyond Research and Academia
3
Reactivating Your GPC/SEC Instrument After Shutdown
4
The Scientist’s Value in the Age of Automation
5
